Results 201 to 210 of about 19,830 (241)
Some of the next articles are maybe not open access.

Pseudomyxoma Peritonei

Archives of Surgery, 1980
Thirty-eight patients with pseudomyxoma peritonei were treated at the M. D. Anderson Hospital, Houston, from 1954 to 1978. The various treatment regimens used have provided actuarial survival rates of 54% at five years and 18% at ten years. Local or regional disease was the cause of death in 68% of patients, and no patient died of metastatic disease ...
R N, Fernandez, J M, Daly
openaire   +2 more sources

Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment.

European Journal of Surgical Oncology, 2020
Pseudomyxoma Peritonei (PMP) is a rare peritoneal malignancy, most commonly originating from a perforated epithelial tumour of the appendix. Given its rarity, randomized controlled trials on treatment strategies are lacking, nor likely to be performed in
K. Govaerts   +36 more
semanticscholar   +1 more source

Targeted Genetic Sequencing Analysis of 223 Cases of Pseudomyxoma Peritonei Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Shows Survival Related to GNAS and KRAS Status

Cancer Medicine
Pseudomyxoma peritonei (PMP) is an unusual condition with unique behaviour caused by a mucinous neoplasm, usually arising from the appendix. The aim of this study was to evaluate the prevalence of genomic alterations in clinical specimens of PMP using a ...
J. Gibson   +12 more
semanticscholar   +1 more source

Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei.

Journal of Surgical Research, 2022
INTRODUCTION The pathologic classification of pseudomyxoma peritonei is controversial. This study aimed to standardize the histopathological evaluation of pseudomyxoma peritonei and identify the clinicopathological factors associated with survival ...
A. Lopes   +4 more
semanticscholar   +1 more source

Pseudomyxoma peritonei

Coloproctology, 1997
Pseudomyxoma peritonei is characterized by mucinous ascites and implants throughout the abdominal cavity. Although not a typical malignant entity the disease shows a long-term poor prognosis, because mucinous implants cannot be resected radically. Additional therapy is not able to improve the prognosis.
R. Frese   +3 more
openaire   +3 more sources

Progression to pseudomyxoma peritonei in patients with low grade appendiceal mucinous neoplasms discovered at time of appendectomy.

American Journal of Surgery, 2021
BACKGROUND The discovery of a low grade appendiceal mucinous neoplasm (LAMN) during appendectomy is a rare scenario. These neoplasms can progress to pseudomyxoma peritonei (PMP), however the incidence of progression is not well known.
S. Reiter   +3 more
semanticscholar   +1 more source

Pseudomyxoma peritonei peritonitis

BMJ Case Reports
Pseudomyxoma peritonei (PMP) is a rare neoplastic condition characterised by gelatinous ascites, which generally arise from mucin-producing appendiceal tumours. Presentation is variable but requires prompt recognition to ensure appropriate specialist management due to risk of malignancy.
Pranathi Yannamani   +3 more
openaire   +2 more sources

Pseudomyxoma Peritonei

Current Problems in Surgery, 2008
Robert M, Smeenk   +3 more
openaire   +4 more sources

Managing Recurrent Pseudomyxoma Peritonei in 430 Patients After Complete Cytoreduction and HIPEC: A Dilemma for Patients and Surgeons

Annals of Surgical Oncology, 2021
Nima Ahmadi   +10 more
semanticscholar   +1 more source

Prevalence and incidence of pseudomyxoma peritonei in urban China: A nationwide retrospective cohort study.

European Journal of Surgical Oncology, 2022
Jingnan Feng   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy